Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson’s Disease Patients

The potential role of preventing atherosclerosis by induction of neonatal tolerance to VLDL

(2011) Kai Cui et al.   CELLULAR IMMUNOLOGY

Body mass index in Parkinson’s disease: A meta-analysis

(2011) Marjolein A. van der Marck et al.   PARKINSONISM & RELATED DISORDERS

Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells

(2009) Giuseppe Danilo Norata et al.   ATHEROSCLEROSIS

Nonmotor symptoms in Parkinson disease: the PRIAMO study

(2009) Ronald F. Pfeiffer   Nature Reviews Neurology

Mixed Dyslipidemia, Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease: Clinical Implications

(2008) Christopher P. Cannon   AMERICAN JOURNAL OF CARDIOLOGY

Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies

(2008) Julien Labreuche et al.   ATHEROSCLEROSIS

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

(2008) I. Holme et al.   JOURNAL OF INTERNAL MEDICINE

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

(2008) Giulio Scigliano et al.   PARKINSONISM & RELATED DISORDERS